BRIEF—BI0SECURE Act left out of 2025 US Defense Bill

The proposed US BIOSECURE Act was this week left out of the House Rules Committee’s final list of amendments to be voted on for inclusion in the NDAA, an agreement that specifies the budget and spending for the US Department of Defense.

The lack of inclusion may, therefore, provide somewhat of a respite to both global supply chain concerns and for Chinese service providers targeted by lawmakers.

The recent pause in its trajectory, the result of parliamentary procedures rather than opposition to the legislation, provides an opportunity to consider what the BIOSECURE Act would and would not accomplish, how it may be modified prior to enactment, and next steps Congress could take to address challenges facing the US life sciences industry, noted BioCentury.